Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
11/2003
11/13/2003WO2003093268A1 7-aminoimidazotriazones
11/13/2003WO2003093267A1 7-aryl-3,9-diazabicyclo(3.3.1)non-6-ene derivatives and their use as renin inhibitors in the treatment of hypertension, cardiovascular or renal diseases
11/13/2003WO2003093266A1 Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity
11/13/2003WO2003093265A1 Dimeric polycyclic compounds for the treatment of tumors
11/13/2003WO2003093242A2 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
11/13/2003WO2003092695A1 Bicyclo 4.4.0 antiviral derivatives
11/13/2003WO2003092595A2 Tyrosine kinase inhibitors
11/13/2003WO2003092586A2 Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity
11/13/2003WO2003092580A2 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor
11/13/2003WO2003076417A3 Oxo-azabicyclic compounds
11/13/2003WO2003057165A3 COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF AMYLOID-β PEPTIDE-RELATED DISORDERS
11/13/2003WO2003053344A3 Substituted 2-methyl-benzimidazole respiratory syncytial virus antiviral agents
11/13/2003US20030212275 Process for the preparation of chemical compounds
11/13/2003US20030212270 Viricides; antitumor agents
11/13/2003US20030212120 Compositions comprising a substituted benzimidazole useful for treating immunomediated inflammatory disorders
11/13/2003US20030212116 Contorlling plant disease
11/13/2003US20030212101 Respiratory system disorders; antiinflammatory agents; psychological disorders
11/13/2003US20030212097 Osteoporosis, antiarthrtic agents; antitumor agents
11/13/2003US20030212096 Analgesics, antiinflammatory agents, autoimmune disease, viricides, bactericides, antitumor agents, organ grafting, central nervous system disorders
11/13/2003US20030212095 New bispidine compounds and their use in the treatment of cardiac arrhythmias
11/13/2003US20030212094 Novel cyclic amide derivatives
11/13/2003US20030212093 Imidazonaphthyridines
11/13/2003US20030212092 Aryl ether substituted imidazoquinolines
11/13/2003US20030212091 Aryl ether substituted imidazoquinolines
11/13/2003US20030212084 Naphthrydine compounds and their azaisosteric analogues as antibacterials
11/13/2003US20030212065 Using a imidazolo(4,5,1-ij)quinoline compound
11/13/2003US20030212057 Substituted piperidines, medicaments containing these compounds, and methods for the production thereof
11/13/2003US20030212054 Therapy, prevention thrombosis; anticoagulant
11/13/2003US20030211164 Method for preparing microparticles having a selected polymer molecular weight
11/13/2003US20030211159 Gaseous extraction of solvent
11/13/2003CA2484599A1 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor
11/13/2003CA2483865A1 7-aminoimidazotriazones
11/13/2003CA2483084A1 Tyrosine kinase inhibitors
11/13/2003CA2462645A1 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
11/12/2003EP1361225A1 Compounds substituted with bicyclic amino groups
11/12/2003EP1360486A2 Screening method for identifying compounds that selectively induce interferon alpha
11/12/2003EP1360337A1 Ecteinascidin family compounds: compositions and methods
11/12/2003EP1360186A2 Carboline derivatives
11/12/2003EP1360185A2 Carboline derivatives
11/12/2003EP1359916A1 Imidazolyl derivatives as corticotropin releasing factor inhibitors
11/12/2003EP1359908A1 Quinolines and nitrogenated derivatives thereof substituted in 4-position by a piperidine-containing moiety and their use as antibacterial agents
11/12/2003EP1206265B1 Src kinase inhibitor compounds
11/12/2003EP1140097B1 Products comprising trihydroxystilbenes and derivatives thereof and methods for their manufacture and use
11/12/2003EP1058549A4 THROMBIN OR FACTOR Xa INHIBITORS
11/12/2003EP1019373B1 1-acyl-3-phenyl-3-(3-piperidinopropyl)piperidine derivatives as human nk3 receptor selective antagonists
11/12/2003EP0861243B1 Heterocyclic compounds as bradykinin antagonists
11/12/2003CN1455671A Methods for delaying recurrence of herpes virus symptoms
11/12/2003CN1127498C Pyridine derivatives, process for preparing the same, and intermediate therefor
11/11/2003US6646124 Gamma-aminobutyric acid (GABA) agonists, antagonists or inverse agonists; treatment of anxiety, Down Syndrome, sleep, cognitive and seizure disorders, and overdose with benzodiazepine drugs
11/11/2003US6645990 For prophylaxis and therapy of diseases, such as cell proliferation or apoptosis mediated diseases
11/11/2003US6645981 Antimicrobial quinolones, their compositions and uses
11/11/2003US6645976 Indolizine SPLA2inhibitors
11/11/2003US6645970 Preventing T-cell mediated acute or chronic inflammatory diseases or disorders, autoimmune diseases, graft rejection or cancer
11/11/2003US6645969 Antiproliferative, anticarcinogenic, and antiinflammatory agents; treatment of leukemia, psoriasis, bone disorders, and atherosclerosis
11/11/2003US6645918 N-(Triazolo(1,5-a)pyrimidinyl)thiophenesulfonamide compounds; postemergence herbicides; agriculture
11/11/2003US6645428 Fluorescent monomers and tagged treatment polymers containing same for use in industrial water systems
11/11/2003CA2078811C Sulphonylaminocarbonyltriazolinones having two substituents bonded via oxygen
11/06/2003WO2003091290A1 Method for reduction of residual organic solvent in carbomer
11/06/2003WO2003091264A2 Non nucleoside reverse transcriptase inhibitors
11/06/2003WO2003091253A1 Nitrosated imidazopyridines
11/06/2003WO2003091251A1 1,2,3,4,7,8-hexahydro-6h-[1,4]diazepino[6,7,1-1j]quinoline derivatives as antipsychotic and antiobesity agents
11/06/2003WO2003091250A1 [1,4]diazepino[6,7,1-ij]quinoline derivatives as anti psychotic and antiobesity agents
11/06/2003WO2003091247A2 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
11/06/2003WO2003091246A1 Pyrrole derivatives as inhibitors of erk2 and uses thereof
11/06/2003WO2003090691A2 Method and compositions for identifying anti-hiv therapeutic compounds
11/06/2003WO2003090690A2 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such
11/06/2003WO2003090680A2 Novel phenyl derivatives as inducers of apoptosis
11/06/2003WO2003090677A2 Somatostatin analogue compounds
11/06/2003WO2003080125A3 Benzimidazoles and their use as mitogen-activated- and rho-kinase inhibitors
11/06/2003WO2003080112A3 Imidazoquinolineamines as adjuvants in hiv dna vaccination
11/06/2003WO2003049688A3 Bis hydrochloride monohydrate salt of rsv fusion inhibitor
11/06/2003WO2003040395A3 Universal nucleotides for nucleic acid analysis
11/06/2003WO2003026587A3 Compounds useful for treating hepatitus c virus
11/06/2003WO2002094799A3 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
11/06/2003WO2002076979A8 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin ii receptor antagonists
11/06/2003WO2002060900A8 Antagonists of mcp-1 function and methods of use thereof
11/06/2003US20030208069 Method for producing 8-methoxy-quinoline carboxylic acids
11/06/2003US20030208066 4-((4-But-2-ynyloxy-benzenesulfonyl)-methyl-amino)-1,3-dimethy l-1H- pyrazolo(3,4-b)and dericatives; bioavailability; no pharmacokinetic problems; bioselectiveity; rheumatoid arthritis, osteoarthritis, sepsis, AIDS, ulcerative colitis
11/06/2003US20030207913 Azabicyclic-substituted-heteroaryl compounds for the treatment of disease
11/06/2003US20030207911 For treatment of disease associated with the adenosine A2 receptor such as Alzheimer's disease and Parkinson's disease
11/06/2003US20030207910 Treatment of HIV and AIDS
11/06/2003US20030207906 Chemical compounds
11/06/2003US20030207894 1,4-Disubstituted benzenes as insecticides
11/06/2003US20030207888 Serotonin receptor agonists such as 6-chloro-4-methyl-1,2,3,4 -tetrahydro-2,4a,5-triaza-fluorene, used for prophylaxis of nervous system, cardiovascular, gastrointestinal, eating or sleep disorders, and as antidiabetic agents
11/06/2003US20030207887 Farnesyl transferase inhibiting 6-heterocyclylmethyl quinoline and quinazoline derivatives
11/06/2003US20030207885 Nitrogen compounds such as 6-chloro-3-ethyl-2-(2-thiazol-2-yl -imidazol-1-ylmethyl)-imidazo(1,2-b)pyridazine used for prophylaxis of nervous system disorders
11/06/2003US20030207883 Indazole benzimidazole compounds
11/06/2003US20030207880 Heterocycle carboxamides as antiviral agents
11/06/2003US20030207877 Pyridoquinoxaline antivirals
11/06/2003US20030207868 Substituted 2-methyl-benzimidazole respiratory syncytial virus antiviral agents
11/06/2003US20030207867 Method of treating a male or female animal in the treatment of a condition where inhibition of a cGMP-specific PDE is of a therapeutic benefit comprising treating said animal with an effective amount of a pharmaceutical composition with carriers
11/06/2003US20030207842 Activity as non-covalent inhibitors of urokinase and having activity in reducing or inhibiting blood vessel formation are provided. These compounds have at a group having a guanidino moiety or derivative thereof. These compounds are useful for
11/06/2003US20030206869 Delivery of antidepressants through an inhalation route
11/06/2003US20030206868 Immune response modifier compounds for treatment of th2 mediated and related diseases
11/06/2003US20030205707 Electroluminescent materials
11/06/2003CA2484090A1 Nitrosated imidazopyridines
11/06/2003CA2483314A1 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
11/06/2003CA2482455A1 1,2,3,4,7,8-hexahydro-6h-[1,4]diazepino[6,7,1-ij]quinoline derivatives as antipsychotic and antiobesity agents
11/06/2003CA2481449A1 Method and compositions for identifying anti-hiv therapeutic compounds
11/06/2003CA2481285A1 Non nucleoside reverse transcriptase inhibitors
1 ... 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 ... 646